Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment.
Matthew E Hirschtritt, Michael H Bloch, Carol A Mathews
https://pubmed.ncbi.nlm.nih.gov/28384832Actively Recruiting
Age: 18Years +
All Genders
ID05881356
Understanding the Patient Perspective: An Observational Study on Experiences of OCD Clinical Trial Patients
Led by Power Life Sciences Inc. · Updated on 2023-05-31
500
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on people with obsessive-compulsive disorder (OCD) who take part in clinical trials. It aims to understand the challenges that affect patients' ability to join or finish such trials. Since clinical trials often include certain demographic groups more than others, this study seeks to gather data from diverse groups to identify common patterns and provide insights that could help future OCD patients. The study observes participants without giving any treatment or intervention. It collects information about their experiences throughout the clinical trial process. The research is conducted by Power Life Sciences Inc. and does not involve any experimental therapies or procedures. Participants will provide data over time about their decisions to enroll in OCD clinical studies and whether they complete these trials. Researchers will track the rate of enrollment within three months and the number of participants who stay in a clinical trial until completion over twelve months. Participants will be asked to comply with scheduled visits and other study requirements during this period.
CONDITIONS
Brief Title
Discovering Factors in the Clinical Study Journey of Patients With OCD
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Ability to provide written informed consent prior to participation and any related procedures
- Diagnosis of obsessive-compulsive disorder (OCD)
- Willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other study requirements
You will not qualify if you...
- Pregnant or lactating women
- Currently enrolled in another research study
- Any mental or medical condition preventing informed consent or participation in the trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Monitoring
Duration - Up to 12 months
Participants with obsessive-compulsive disorder are observed through scheduled visits to understand their experiences in clinical trials.
Visits scheduled over 12 months depending on study requirements
Trial Site Locations
Total: 1 location
1
Power Life Sciences
San Francisco, California, United States, 94107
Actively Recruiting
Loading map...
Research Team
M
Michael B Gill
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
Umberto Albert, Donatella Marazziti, Gabriele Di Salvo...
https://pubmed.ncbi.nlm.nih.gov/29278206Evolution of LDH isozymes during programmed cell death.
J M Bidlack, R A Lockshin
https://pubmed.ncbi.nlm.nih.gov/963971